Skip to content

Drug interactions

Avapritinib + Primaquine

Severity: Moderate

Avapritinib and Primaquine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Avapritinib is a CYP3A4 substrate, and a weak CYP3A4 inhibitor such as primaquine could modestly raise exposure. Higher avapritinib exposure may increase adverse effects such as cognitive effects, intracranial bleeding or edema.

What this interaction means in plain words

Avapritinib and Primaquine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Avapritinib belongs to Oncology; Primaquine belongs to Anti Parasitic.

Evidence level: Low

Why it happens

Possible weak inhibition of CYP3A4-mediated avapritinib metabolism.

What to do

Monitor for avapritinib toxicity, including cognitive changes and bleeding, and reduce the dose if adverse effects emerge. Consider an alternative antimalarial if appropriate.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Avapritinib and Primaquine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Avapritinib with Primaquine?

MediHelp rates the interaction as moderate. Avapritinib and Primaquine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Avapritinib is a CYP3A4 substrate, and a weak CYP3A4 inhibitor such as primaquine could modestly raise exposure. Higher avapritinib exposure may increase adverse effects such as cognitive effects, intracranial bleeding or edema.

How serious is the interaction between Avapritinib and Primaquine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for avapritinib toxicity, including cognitive changes and bleeding, and reduce the dose if adverse effects emerge. Consider an alternative antimalarial if appropriate.

What other medicines interact with Primaquine?

MediHelp also lists interactions of Primaquine with, for example, Pimozide, Amiodarone, Amisulpride. The full list is on the Primaquine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in